EUVIMEDEUVIMED entdecken
Crossref

Combination of ultra‐performance liquid chromatography‐quadrupole time‐of‐flight mass spectrometry and network pharmacology to reveal the key effective compounds and mechanism of Shengxian decoction for ameliorating doxorubicin cardiotoxicity

Guangyang Jiao iD, Yejian Wang, Yue Song, Yuxin Chen, Xiangcheng Fan iD, Qing Zhao, Tao Pang, Feng Zhang iD, Wansheng Chen iD

Journal of Separation Science · 2024

DOI: 10.1002/jssc.202300867 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Separation Science, 2024. Verfasst von Guangyang Jiao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, P. R. China. Hauptthemen laut MEDLINE: Doxorubicin, Drugs, Chinese Herbal, Network Pharmacology, Rats, Sprague-Dawley. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Science and Technology Commission of Shanghai Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Shengxian decoction, a traditional Chinese medicinal prescription, has been shown to alleviate doxorubicin‐induced chronic heart failure. This study established an ultra‐performance liquid chromatography‐quadrupole time‐of‐flight mass spectrometry method to separate and characterize the complex chemical compositions of Shengxian decoction, and the absorbed compounds in the bio‐samples of the cardiotoxicity rats with chronic heart failure after its oral delivery. Note that 116 chemical compounds were identified from Shengxian decoction in vitro, 81 more than previously detected. Based on the three‐dimensional data of these compounds, 28 absorbed compounds were confirmed in vivo. Network pharmacology and molecular docking experiments indicated that timosaponin B‐II, timosaponin A‐III, gitogenin, and 7,8‐didehydrocimigenol were recognized as the key effective compounds to exert effects against doxorubicin cardiotoxicity by acting on targets such as caspase 3, cyclin‐dependent kinase 1, cyclin‐dependent kinase 4, receptor tyrosine‐protein kinase erbB‐2, and mitogen‐activated protein kinase 1 in p53 and phosphatidylinositol 3‐kinase‐Akt signaling pathways. This study developed the understanding of the composition of Shengxian decoction for the treatment of doxorubicin cardiotoxicity, as well as a feasible strategy to elucidate the effective constituents in traditional Chinese medicines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinDrugs, Chinese HerbalNetwork PharmacologyRats, Sprague-DawleyAnimalsRatsChromatography, High Pressure LiquidMaleMass SpectrometryCardiotoxicityMolecular Docking SimulationDrug Combinations

Stichwörter der Autor:innen

Shengxian decoctionUHPLC‐Q‐TOF/MSdoxorubicin cardiotoxicitykey effective compoundsnetwork pharmacology

Substanzen

DoxorubicinDrugs, Chinese Herbalfructus schizandrae, radix ginseng, radix ophiopogonis drug combinationDrug Combinations

Autor:innen und Institutionen

  • Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, P. R. China.
  • Department of Pharmacy, Changzheng Hospital, Naval Medical University (Second Military Medical University), Shanghai, P. R. China.
  • Department of Pharmacology, Anhui University of Chinese Medicine, Anhui, P. R. China.
  • Agilent Technologies (China) Co., Ltd., Shanghai, P. R. China.
  • Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P. R. China.
  • Department of Pharmacy, The Fourth Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang, P. R. China.

ORCID-Profile: Guangyang Jiao, Xiangcheng Fan, Feng Zhang, Wansheng Chen

Förderung

  • National Key R&D Program of China
  • National Natural Science Foundation of China
  • Science and Technology Commission of Shanghai Municipality
  • Organizational Key Research and Development Program of Shanghai University of Traditional Chinese Medicine
  • Naval Medical University (Second Military Medical University), Far East Talent Project
  • Changzheng Hospital, Naval Medical University (Second Military Medical University), Jin-Zi-Ta Talent Project
  • National Key Research and Development Program of China

Zitieren

APA

Jiao, G., Wang, Y., Song, Y., Chen, Y., Fan, X., Zhao, Q., Pang, T., Zhang, F., & Chen, W. (2024). Combination of ultra‐performance liquid chromatography‐quadrupole time‐of‐flight mass spectrometry and network pharmacology to reveal the key effective compounds and mechanism of Shengxian decoction for ameliorating doxorubicin cardiotoxicity. Journal of Separation Science. https://doi.org/10.1002/jssc.202300867

Vancouver

Jiao G, Wang Y, Song Y, Chen Y, Fan X, Zhao Q, et al. Combination of ultra‐performance liquid chromatography‐quadrupole time‐of‐flight mass spectrometry and network pharmacology to reveal the key effective compounds and mechanism of Shengxian decoction for ameliorating doxorubicin cardiotoxicity. Journal of Separation Science. 2024. doi:10.1002/jssc.202300867

BibTeX
@article{Jiao2024,
  author = {Jiao, Guangyang and Wang, Yejian and Song, Yue and Chen, Yuxin and Fan, Xiangcheng and Zhao, Qing and Pang, Tao and Zhang, Feng and Chen, Wansheng},
  title = {Combination of ultra‐performance liquid chromatography‐quadrupole time‐of‐flight mass spectrometry and network pharmacology to reveal the key effective compounds and mechanism of Shengxian decoction for ameliorating doxorubicin cardiotoxicity},
  journal = {Journal of Separation Science},
  year = {2024},
  doi = {10.1002/jssc.202300867}
}
Kostenlos starten →